Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Association of the Trough, Peak/Trough Ratio of Imatinib, Pyridine-N-Oxide Imatinib and ABCG2 SNPs 34 G>A and SLCO1B3 334 T>G With Imatinib Response in Egyptian Chronic Myeloid Leukemia Patients.
Front Oncol. 2020 Aug 19;10:1348. doi: 10.3389/fonc.2020.01348. eCollection 2020.
Front Oncol. 2020.
PMID: 32974132
Free PMC article.
Imatinib mesylate (IM) is highly efficacious in the treatment of chronic myeloid leukemia (CML). ...Blood samples were withdrawn at least 30 days after drug administration, and trough and peak concentrations of imatinib, N-des-methyl imatinib, and p …
Imatinib mesylate (IM) is highly efficacious in the treatment of chronic myeloid leukemia (CML). ...Blood samples were withdra …
An ultra-specific and sensitive sandwich ELISA for imatinib using two anti-imatinib antibodies.
Saita T, Yamamoto Y, Hosoya K, Yamamoto Y, Kimura S, Narisawa Y, Shin M.
Saita T, et al.
Anal Chim Acta. 2017 May 29;969:72-78. doi: 10.1016/j.aca.2017.03.034. Epub 2017 Mar 27.
Anal Chim Acta. 2017.
PMID: 28411632
This paper reports an ultra-specific and sensitive sandwich ELISA for determination of the tyrosine kinase inhibitor imatinib using two anti-imatinib antibodies. The anti-imatinib antibodies were obtained by two partial structures of imatinib as hapten …
This paper reports an ultra-specific and sensitive sandwich ELISA for determination of the tyrosine kinase inhibitor imatinib using t …
Item in Clipboard
Cite
Cite